Ad
related to: mifepristone for sale
Search results
Results From The WOW.Com Content Network
Mifepristone, and also known by ... (US$30 (equivalent to $58.28 in 2023) billion annual revenue) announced the end of its manufacture and sale of Mifegyne (US$3.44 ...
In 2000, GenBioPro's generic version of mifepristone was approved for medication abortion, as part of a two-drug regimen in combination with misoprostol. In 2023, GenBioPro sued the FDA to obtain a legal judgement confirming that mifepristone could continue to be sold, in spite of anti-abortion laws passed in some states.
After the U.S. Supreme Court's decision to maintain access the abortion pill mifepristone, physicians will be able to keep prescribing the drug as a lower court case on its FDA approval moves ...
Aid Access is a nonprofit organization that provides access to medication abortion by mail to the United States and worldwide. It describes its work as a harm reduction strategy designed to provide safe access to mifepristone and misoprostol for those able to become pregnant in the United States who may not otherwise have access to abortion or miscarriage management services. [2]
In April 2023, congressional Democrats urged the White House to ignore a federal judge's decision to block the sale of the abortion pill mifepristone. The Biden administration rejected the suggestion.
For premium support please call: 800-290-4726 more ways to reach us
Danco Laboratories is a pharmaceutical distributor located in midtown Manhattan which distributes the abortifacient drug mifepristone under the brand name Mifeprex. Mifeprex is the only drug distributed by Danco, although the company plans to expand to other drugs in the future.
The FDA approved mifepristone in 2000 as part of a two-drug regimen to end a pregnancy. Over the course of two decades, the agency loosened restrictions it initially placed on the drug’s use.